AGMB is AgomAb Therapeutics NV (Healthcare) — a non-dividend-paying stock. Trading at $15.78. Market cap: $777M.
Stock snapshot
| Price | $15.78 |
| Market cap | $777M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About AGMB
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Frequently asked
What is AGMB's current stock price?
AGMB (AgomAb Therapeutics NV) is currently trading at $15.78.
Does AGMB pay a dividend?
AGMB (AgomAb Therapeutics NV) does not currently pay a regular dividend.
Track AGMB in DiviDrip
Add AGMB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search AGMB and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.